Construct: ORF ccsbBroadEn_07330
Construct Description:
- Construct Type:
- ORF
- Other Identifiers:
- ORF015039.1_s300c1, BRDN0000392784
- DNA Barcode:
- None
- Epitope Tag:
- None
- Notes:
- No stop codon in insert
Originally Annotated References:
- Gene:
- SGCE (8910)
Vector Information:
- Vector Backbone:
- pDONR223
- Pol II Cassette 1:
- n/a
- Pol II Cassette 2:
- n/a
- Selection Marker:
- n/a
- Visible Reporter:
- n/a
- Epitope Tag:
- n/a
Current transcripts matched by this ORF:
| Taxon | Gene | Symbol | Description | Transcript | Nuc. Match %[?]A simple nucleotide-based global alignment percentage, calculated as follows: total nt. matches ---------------------------------- aligned length (incl. gaps) |
Prot. Match %[?]A simple amino acid-based global alignment percentage, calculated as follows: total aa. matches ---------------------------------- aligned length (incl. gaps) |
Match Diffs[?]This field may contain sequence annotations in HGVS format. For more information about HGVS annotations, please refer to the HGVS Quick Reference Guide. | |
|---|---|---|---|---|---|---|---|---|
| 1 | human | 8910 | SGCE | sarcoglycan epsilon | NM_003919.3 | 99.8% | 99.5% | 146A>G;1196C>A |
| 2 | human | 8910 | SGCE | sarcoglycan epsilon | NM_001346717.2 | 97.7% | 97.4% | 146A>G;1037_1038ins27;1169C>A |
| 3 | human | 8910 | SGCE | sarcoglycan epsilon | NM_001099401.2 | 94.4% | 94.1% | 146A>G;1196C>A;1254_1328del |
| 4 | human | 8910 | SGCE | sarcoglycan epsilon | XM_011516665.3 | 92.9% | 92.2% | (many diffs) |
| 5 | human | 8910 | SGCE | sarcoglycan epsilon | NM_001099400.2 | 92.8% | 91.7% | (many diffs) |
| 6 | human | 8910 | SGCE | sarcoglycan epsilon | NM_001346713.2 | 92.2% | 91.9% | 109_216del;254A>G;1304C>A |
| 7 | human | 8910 | SGCE | sarcoglycan epsilon | NM_001346719.2 | 91.8% | 91.3% | (many diffs) |
| 8 | human | 8910 | SGCE | sarcoglycan epsilon | XM_011516666.3 | 91% | 90.3% | (many diffs) |
| 9 | human | 8910 | SGCE | sarcoglycan epsilon | NM_001301139.2 | 90.5% | 90.3% | 108_109ins123;1073C>A |
| 10 | human | 8910 | SGCE | sarcoglycan epsilon | NM_001346715.2 | 90.3% | 90% | (many diffs) |
| 11 | human | 8910 | SGCE | sarcoglycan epsilon | NM_001362807.2 | 89.7% | 89.2% | (many diffs) |
| 12 | human | 8910 | SGCE | sarcoglycan epsilon | NM_001362809.2 | 88.4% | 88.3% | 108_109ins123;914_915ins27;1046C>A |
| 13 | human | 8910 | SGCE | sarcoglycan epsilon | XM_011516663.2 | 86.2% | 85.6% | (many diffs) |
| 14 | human | 8910 | SGCE | sarcoglycan epsilon | XM_011516667.2 | 85.4% | 84.5% | (many diffs) |
| 15 | human | 8910 | SGCE | sarcoglycan epsilon | XM_017012763.1 | 85.4% | 84.5% | (many diffs) |
| 16 | human | 8910 | SGCE | sarcoglycan epsilon | XM_011516664.2 | 84.5% | 83.8% | (many diffs) |
| 17 | human | 8910 | SGCE | sarcoglycan epsilon | XM_024446985.1 | 84.2% | 83.7% | (many diffs) |
| 18 | human | 8910 | SGCE | sarcoglycan epsilon | XM_024446986.1 | 82.3% | 81.7% | (many diffs) |
| 19 | human | 8910 | SGCE | sarcoglycan epsilon | NM_001346720.2 | 79% | 78.9% | 0_1ins273;923C>A |
| 20 | human | 8910 | SGCE | sarcoglycan epsilon | NM_001362808.2 | 77% | 76.8% | 0_1ins273;764_765ins27;896C>A |
| 21 | human | 8910 | SGCE | sarcoglycan epsilon | XM_011516669.3 | 73.5% | 73% | (many diffs) |
| 22 | human | 8910 | SGCE | sarcoglycan epsilon | XM_017012767.1 | 71.6% | 71% | (many diffs) |
| 23 | mouse | 20392 | Sgce | sarcoglycan, epsilon | NM_011360.3 | 89.2% | 94.5% | (many diffs) |
| 24 | mouse | 20392 | Sgce | sarcoglycan, epsilon | NM_001130190.1 | 87.1% | 92.1% | (many diffs) |
| 25 | mouse | 20392 | Sgce | sarcoglycan, epsilon | NM_001130191.1 | 85.2% | 90.3% | (many diffs) |
| 26 | mouse | 20392 | Sgce | sarcoglycan, epsilon | XM_006505023.1 | 84.7% | 88.9% | (many diffs) |
| 27 | mouse | 20392 | Sgce | sarcoglycan, epsilon | NM_001130189.1 | 82.9% | 87.1% | (many diffs) |
| 28 | mouse | 20392 | Sgce | sarcoglycan, epsilon | NM_001130188.1 | 82.4% | 87.3% | (many diffs) |
| 29 | mouse | 20392 | Sgce | sarcoglycan, epsilon | XM_006505022.3 | 80.6% | 85.6% | (many diffs) |
| 30 | mouse | 20392 | Sgce | sarcoglycan, epsilon | XM_006505021.3 | 80.5% | 85.2% | (many diffs) |
| 31 | mouse | 20392 | Sgce | sarcoglycan, epsilon | XM_006505019.3 | 78.6% | 82.4% | (many diffs) |
| 32 | mouse | 20392 | Sgce | sarcoglycan, epsilon | XM_006505020.3 | 76.9% | 80.8% | (many diffs) |
| 33 | mouse | 20392 | Sgce | sarcoglycan, epsilon | XM_006505024.3 | 67% | 71.3% | (many diffs) |
| 34 | mouse | 20392 | Sgce | sarcoglycan, epsilon | XM_011241051.2 | 42.5% | 42.9% | (many diffs) |
Sequence Information
Note: uppercase bases indicate empirically verified sequence.
- ORF start:
- 66
- ORF end:
- 1377
- ORF length:
- 1311
- Sequence:
-
1 gttcgttgca acaaattgat gagcaatgct tttttataat gccaaCTTTG TACAAAAAAG 61 TTGGCATGCA ATTGCCCCGG TGGTGGGAGC TGGGAGACCC CTGTGCTTGG ACGGGACAGG 121 GTCGGGGGAC ACGCAGGATG AGCCCCGCGA CCACTGGCAC ATTCTTGCTG ACAGTGTACA 181 GTATTTTCTC CAAGGTACAC TCCGATCGGA GTGTATACCC ATCAGCAGGT GTCCTCTTTG 241 TTCATGTTTT GGAAAGAGAA TATTTTAAGG GGGAATTTCC ACCTTACCCA AAACCTGGCG 301 AGATTAGTAA TGATCCCATA ACATTTAATA CAAATTTAAT GGGTTACCCA GACCGACCTG 361 GATGGCTTCG ATATATCCAA AGGACACCAT ATAGTGATGG AGTCCTATAT GGGTCCCCAA 421 CAGCTGAAAA TGTGGGGAAG CCAACAATCA TTGAGATAAC TGCCTACAAC AGGCGCACCT 481 TTGAGACTGC AAGGCATAAT TTGATAATTA ATATAATGTC TGCAGAAGAC TTCCCGTTGC 541 CATATCAAGC AGAATTCTTC ATTAAGAATA TGAATGTAGA AGAAATGTTG GCCAGTGAGG 601 TTCTTGGAGA CTTTCTTGGC GCAGTGAAAA ATGTGTGGCA GCCAGAGCGC CTGAACGCCA 661 TAAACATCAC ATCGGCCCTA GACAGGGGTG GCAGGGTGCC ACTTCCCATT AATGACCTGA 721 AGGAGGGCGT TTATGTCATG GTTGGTGCAG ATGTCCCGTT TTCTTCTTGT TTACGAGAAG 781 TTGAAAATCC ACAGAATCAA TTGAGATGTA GTCAAGAAAT GGAGCCTGTA ATAACATGTG 841 ATAAAAAATT TCGTACTCAA TTTTACATTG ACTGGTGCAA AATTTCATTG GTTGATAAAA 901 CAAAGCAAGT GTCCACCTAT CAGGAAGTGA TTCGTGGAGA GGGGATTTTA CCTGATGGTG 961 GAGAATACAA ACCCCCTTCT GATTCTTTGA AAAGCAGAGA CTATTACACG GATTTCCTAA 1021 TTACACTGGC TGTGCCCTCG GCAGTGGCAC TGGTCCTTTT TCTAATACTT GCTTATATCA 1081 TGTGCTGCCG ACGGGAAGGC GTGGAAAAGA GAAACATGCA AACACCAGAC ATCCAACTGG 1141 TCCATCACAG TGCTATTCAG AAATCTACCA AGGAGCTTCG AGACATGTCC AAGAATAGAG 1201 AGATAGCATG GCCCCTGTCA ACGCTTCCTG TGTTCCACCC TGTGACTGGG GAAATCATAC 1261 ATCCTTTACA CACAGACAAC TATGATAGCA CAAACATGCC ATTGATGCAA ACGCAGCAGA 1321 ACTTGCCACA TCAGACTCAG ATTCCCCAAC AGCAGACTAC AGGTAAATGG TATCCCTGCC 1381 CAACTTTCTT GTACAAAGTt ggcattataa gaaagcattg cttatcaatt tgttgcaacg 1441 aac